×
About 7,593 results

ALLMedicine™ Movement Disorders Center

Research & Reviews  2,536 results

Cannabidiol and substance use disorder: Dream or reality.
https://doi.org/10.1016/j.neuropharm.2022.108948
Neuropharmacology Karimi-Haghighi S, Razavi Y et. al.

Jan 16th, 2022 - Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing effects of addictive drugs such as cocaine, methamphetamine (METH), and morphin...

Pediatric GAD-65 Autoimmune Encephalitis: Assessing Clinical Characteristics and Respon...
https://doi.org/10.1016/j.pediatrneurol.2021.12.007
Pediatric Neurology; Harmon A, Stingl C et. al.

Jan 16th, 2022 - Glutamic acid decarboxylase (GAD) encephalitis is a neuroinflammatory disease characterized by a broad range of symptoms including cognitive deficits, behavioral changes, and seizures. Children with this disorder have heterogeneous presentations, ...

PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a ret...
https://doi.org/10.1186/s12883-021-02546-5 10.1007/s00415-019-09337-6 10.1111/j.1600-0404.1998.tb00633.x 10.1111/j.1468-1331.2011.03630.x 10.1002/mds.26485 10.3109/00365521.2015.1055793 10.1212/WNL.0000000000001500 10.1136/jnnp.55.3.181 10.1016/j.parkreldis.2017.02.020 10.1016/j.parkreldis.2015.05.014
BMC Neurology; Simoni S, Nigro P et. al.

Jan 15th, 2022 - Reducing percutaneous endoscopic gastrostomies with jejunal extension tubes (PEG-J) related complications is vital to the long-term preservation of duodenal levodopa infusion (DLI) in advanced Parkinson's disease (APD). Here, we provide data on th...

Cholinergic Receptor Imaging in Dystonia
https://clinicaltrials.gov/ct2/show/NCT02689466

Jan 14th, 2022 - Dystonia is a heterogeneous group of movement disorders characterized by abnormal muscle contractions resulting in abnormal postures and movements. The spectrum of dystonia includes focal, segmental, multifocal, and generalized presentations with ...

Deep Brain Stimulation Surgery for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT01581580

Jan 12th, 2022 - Objective: The objective of this protocol is to provide DBS surgery and to collect physiology and efficacy data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), dystonia, and ess...

see more →

Guidelines  3 results

Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disord...
https://doi.org/10.1002/mds.28465
Movement Disorders : Official Journal of the Movement Dis... Rusz J, Tykalova T et. al.

Dec 30th, 2020 - Most patients with movement disorders have speech impairments resulting from sensorimotor abnormalities that affect phonatory, articulatory, and prosodic speech subsystems. There is widespread cross-discipline use of speech recordings for diagnost...

ACR Appropriateness Criteria® Movement Disorders and Neurodegenerative Diseases.
https://doi.org/10.1016/j.jacr.2020.01.042
Journal of the American College of Radiology : JACR; , Harvey HB et. al.

May 7th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Dementia and movement disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119123
AJNR. American Journal of Neuroradiology; Dormont D, Seidenwurm DJ et. al.

Jan 15th, 2008 - Dementia and movement disorders.|2008|Dormont D,Seidenwurm DJ, , ,|classification,complications,diagnosis,standards,classification,complications,diagnosis,

see more →

Drugs  12 results see all →

Clinicaltrials.gov  113 results

Cholinergic Receptor Imaging in Dystonia
https://clinicaltrials.gov/ct2/show/NCT02689466

Jan 14th, 2022 - Dystonia is a heterogeneous group of movement disorders characterized by abnormal muscle contractions resulting in abnormal postures and movements. The spectrum of dystonia includes focal, segmental, multifocal, and generalized presentations with ...

Deep Brain Stimulation Surgery for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT01581580

Jan 12th, 2022 - Objective: The objective of this protocol is to provide DBS surgery and to collect physiology and efficacy data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), dystonia, and ess...

Study in Parkinson Disease of Exercise
https://clinicaltrials.gov/ct2/show/NCT04284436

Jan 6th, 2022 - This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the MDS-UPDRS Part III score at 12 months. 370 persons diagnosed with Parkinson's disease who have not yet initiated dopaminergic...

Non-invasive Brain Mapping of Movement Facilitation in Parkinson's Disease
https://clinicaltrials.gov/ct2/show/NCT05179187

Jan 5th, 2022 - The studies proposed here test the overarching hypothesis that different types of cues (visual targets, rhythmic auditory stimuli and reward incentives) facilitate movement through distinct neuroanatomic circuits and electrophysiological mechanism...

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
https://clinicaltrials.gov/ct2/show/NCT03813238

Jan 4th, 2022 - CP (cerebral palsy) refers to a group of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. CP is caused by damage to or abnormalities inside the developing brain that dis...

see more →

News  351 results

Confirmed: No Slowing of Parkinson's Progression With Rasagiline
https://www.medscape.com/viewarticle/962868

Nov 12th, 2021 - A 1-mg daily dose of rasagiline has no disease-modifying effect for patients with Parkinson's disease (PD), new research confirms. Results from a randomized, double-blind, placebo-controlled trial support previous observations that free-water accu...

Type 2 Diabetes Worsens Parkinson's Disease
https://www.medscape.com/viewarticle/962501

Nov 8th, 2021 - Key Takeaways Among adults with recently diagnosed Parkinson's disease, those with concomitant type 2 diabetes had at study entry more severe motor symptoms and a greater overall burden of nonmotor symptoms compared with patients without type 2 di...

Influenza Tied to Long-Term Increased Risk for Parkinson's Disease
https://www.medscape.com/viewarticle/962028

Nov 1st, 2021 - Influenza infection is linked to a subsequent diagnosis of Parkinson's disease (PD) more than 10 years later, resurfacing a long-held debate about whether infection increases the risk for movement disorders over the long-term. In a large case-cont...

Avoidant attachment style may drive mood in movement disorders
https://www.mdedge.com/psychiatry/article/247468/movement-disorders/avoidant-attachment-style-may-drive-mood-movement
Heidi Splete

Oct 15th, 2021 - Patients with functional neurological disorders demonstrate higher levels of depression and alexithymia – in addition to signs of an avoidant attachment style – compared with those with other neurological disorders and healthy controls, investigat.

Safer Way to Use Botox to Treat Challenging Dystonia Type?
https://www.medscape.com/viewarticle/960304

Oct 5th, 2021 - When treating oromandibular dystonia (OMD) with botulinum toxin injection to the lateral pterygoid muscle (LPM), an intraoral approach is the safest way to avoid injury to the maxillary artery, new research suggests. OMD causes an involuntary open...

see more →

Patient Education  22 results see all →